Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orforglipron

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 800

NCT06972459

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Orforglipron Dose 1n/rn/rn/rn/rn/r
Orforglipron Dose 2n/rn/rn/rn/rn/r
Orforglipron Dose 3n/rn/rn/rn/rn/r
Orforglipron Dose 4n/rn/rn/rn/rn/r
Placebon/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.